AAAAAA
Results: 1-25/40
Authors:
HANSENNE M
PITCHOT W
MORENO AG
MACHUROT PY
ANSSEAU M
Citation: M. Hansenne et al., THE TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE (TPQ) AND DEPRESSION, European psychiatry, 13(2), 1998, pp. 101-103
Authors:
HANSENNE M
PITCHOT W
PAPART P
ANSSEAU M
Citation: M. Hansenne et al., SEROTONERGIC MODULATION OF THE P300 EVENT-RELATED BRAIN POTENTIAL, Human psychopharmacology, 13(4), 1998, pp. 239-243
Authors:
HANSENNE M
ANSSEAU M
Citation: M. Hansenne et M. Ansseau, CATECHOLAMINERGIC FUNCTION AND TEMPERAMENT IN MAJOR DEPRESSIVE DISORDER - A NEGATIVE REPORT, Psychoneuroendocrinology, 23(5), 1998, pp. 477-483
Authors:
GUELFI JD
ANSSEAU M
CORRUBLE E
SAMUELIAN JC
TONELLI I
TOURNOUX A
PLETAN Y
Citation: Jd. Guelfi et al., A DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF MILNACIPRAN AND FLUOXETINE IN DEPRESSED INPATIENTS, International clinical psychopharmacology, 13(3), 1998, pp. 121-128
Authors:
ABRAINI JH
ANSSEAU M
BISSON T
DEMENDOZA JLJ
THERME P
Citation: Jh. Abraini et al., PERSONALITY-PATTERNS OF ANXIETY DURING OCCUPATIONAL DEEP DIVES WITH LONG-TERM CONFINEMENT IN HYPERBARIC CHAMBER, Journal of clinical psychology, 54(6), 1998, pp. 825-830
Authors:
PAPART P
ANSSEAU M
TIMSITBERTHIER M
Citation: P. Papart et al., INFLUENCE OF DIAZEPAM ON CONTINGENT NEGATIVE-VARIATION, Human psychopharmacology, 12(2), 1997, pp. 95-98
Authors:
RAMAEKERS JG
ANSSEAU M
MUNTJEWERFF ND
SWEENS JP
OHANLON JF
Citation: Jg. Ramaekers et al., CONSIDERING THE P450 CYTOCHROME SYSTEM AS DETERMINING COMBINED EFFECTS OF ANTIDEPRESSANTS AND BENZODIAZEPINES ON ACTUAL DRIVING PERFORMANCEOF DEPRESSED OUTPATIENTS, International clinical psychopharmacology, 12(3), 1997, pp. 159-169
Authors:
HANSENNE M
PITCHOT W
MORENO AG
REGGERS J
MACHUROT PY
ANSSEAU M
Citation: M. Hansenne et al., HARM AVOIDANCE DIMENSION OF THE TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE AND SEROTONIN-1A ACTIVITY IN DEPRESSED-PATIENTS, Biological psychiatry, 42(10), 1997, pp. 959-961
Authors:
PITCHOT W
HANSENNE M
MORENO AG
ANSSEAU M
Citation: W. Pitchot et al., GROWTH-HORMONE RESPONSE TO APOMORPHINE IN OBSESSIVE-COMPULSIVE DISORDER, Journal of psychiatry & neuroscience, 21(5), 1996, pp. 343-345
Authors:
ANSSEAU M
BATAILLE M
BRIOLE G
DENAYER A
FAUCHERE PA
FERRERO F
MERTENS C
REALINI R
ROMBAUT P
VEREECKEN A
TROISFONTAINES B
VANMOFFAERT M
Citation: M. Ansseau et al., CONTROLLED COMPARISON OF TIANEPTINE, ALPRAZOLAM AND MIANSERIN IN THE TREATMENT OF ADJUSTMENT DISORDERS WITH ANXIETY AND DEPRESSION, Human psychopharmacology, 11(4), 1996, pp. 293-298
Authors:
HANSENNE M
PITCHOT W
MORENO AG
ZALDUA IU
ANSSEAU M
Citation: M. Hansenne et al., SUICIDAL-BEHAVIOR IN DEPRESSIVE DISORDER - AN EVENT-RELATED POTENTIALSTUDY, Biological psychiatry, 40(2), 1996, pp. 116-122
Authors:
URCELAYZALDUA I
HANSENNE M
ANSSEAU M
Citation: I. Urcelayzaldua et al., INFLUENCE OF SUICIDAL RISK AND HOPELESSNE SS ON P300 AMPLITUDE IN MAJOR DEPRESSIVE DISORDER, Neurophysiologie clinique, 25(5), 1995, pp. 291-296
Authors:
PITCHOT W
HANSENNE M
MORENO AG
ANSSEAU M
Citation: W. Pitchot et al., GROWTH-HORMONE RESPONSE TO APOMORPHINE IN PANIC DISORDER - COMPARISONWITH MAJOR DEPRESSION AND NORMAL CONTROLS, European archives of psychiatry and clinical neuroscience, 245(6), 1995, pp. 306-308
Authors:
CHARLES G
HANSENNE M
ANSSEAU M
PITCHOT W
MACHOWSKI R
SCHITTECATTE M
WILMOTTE J
Citation: G. Charles et al., P300 IN POSTTRAUMATIC-STRESS-DISORDER, Neuropsychobiology, 32(2), 1995, pp. 72-74
Authors:
PITCHOT W
HANSENNE M
MORENO AG
ANSSEAU M
Citation: W. Pitchot et al., EFFECT OF PREVIOUS ANTIDEPRESSANT THERAPY ON THE GROWTH-HORMONE RESPONSE TO APOMORPHINE, Neuropsychobiology, 32(1), 1995, pp. 19-22
Authors:
PITCHOT W
ANSSEAU M
MORENO AG
LEMBREGHTS M
HANSENNE M
WAUTHY J
REEL C
JAMMAER R
PAPART P
SULON J
LEGROS JJ
Citation: W. Pitchot et al., THE FLESINOXAN 5-HT1A RECEPTOR CHALLENGE IN MAJOR DEPRESSION AND SUICIDAL-BEHAVIOR, Pharmacopsychiatry, 28, 1995, pp. 91-92
CATECHOLAMINERGIC FUNCTION AND P300 AMPLITUDE IN MAJOR DEPRESSIVE DISORDER (P300 AND CATECHOLAMINES)
Authors:
HANSENNE M
PITCHOT W
MORENO AG
PAPART P
TIMSITBERTHIER M
ANSSEAU M
Citation: M. Hansenne et al., CATECHOLAMINERGIC FUNCTION AND P300 AMPLITUDE IN MAJOR DEPRESSIVE DISORDER (P300 AND CATECHOLAMINES), Electroencephalography and clinical neurophysiology. Evoked potentials, 96(2), 1995, pp. 194-196
Authors:
MANCUSO G
BENITO PA
TIRELLI E
ANSSEAU M
Citation: G. Mancuso et al., EFFECTS OF NICOTINE DELIVERED TRANSDERMALLY (PATCH) ON ATTENTION, WORKING-MEMORY AND MOOD, Pflugers Archiv, 430(5), 1995, pp. 32-32
Authors:
PITCHOT W
HANSENNE M
MORENO AG
ANSSEAU M
Citation: W. Pitchot et al., GROWTH-HORMONE RESPONSE TO CLONIDINE IN NONDEPRESSED PATIENTS WITH A HISTORY OF SUICIDE ATTEMPTS, Biological psychiatry, 38(3), 1995, pp. 201-203
Authors:
PITCHOT W
HANSENNE M
MORENO AG
ANSSEAU M
Citation: W. Pitchot et al., THE DEXAMETHASONE SUPPRESSION TEST IN VIOLENT SUICIDE ATTEMPTERS WITHMAJOR DEPRESSION, Biological psychiatry, 37(4), 1995, pp. 273-274
Authors:
PITCHOT W
ANSSEAU M
MORENO AG
HANSENNE M
Citation: W. Pitchot et al., RESPONSES TO MCPP STIMULATION IN DEPRESSED-PATIENTS, The American journal of psychiatry, 152(12), 1995, pp. 1834-1834
Authors:
ANSSEAU M
DARIMONT P
LECOQ A
DENAYER A
EVRARD JL
KREMER P
DEVOITILLE JM
DIERICK M
MERTENS C
MESOTTEN F
MIREL J
TROISFONTAINES B
VANMOFFAERT M
VANBRABANT E
Citation: M. Ansseau et al., CONTROLLED COMPARISON OF NEFAZODONE AND AMITRIPTYLINE IN MAJOR DEPRESSIVE INPATIENTS, Psychopharmacology, 115(1-2), 1994, pp. 254-260
Authors:
ANSSEAU M
PAPART P
TROISFONTAINES B
BARTHOLOME F
BATAILLE M
CHARLES G
SCHITTECATTE M
DARIMONT P
DEVOITILLE JM
DEWILDE J
DUFRASNE M
GILSON H
EVRARD JL
DENAYER A
KREMER P
MERTENS C
SERRE C
Citation: M. Ansseau et al., CONTROLLED COMPARISON OF MILNACIPRAN AND FLUOXETINE IN MAJOR DEPRESSION, Psychopharmacology, 114(1), 1994, pp. 131-137
Authors:
ABRAINI JH
ANSSEAU M
MARTINEZ E
BURNET H
WAUTHY J
LEMAIRE C
Citation: Jh. Abraini et al., DEVELOPMENT OF ANXIETY SYMPTOMS DURING A DEEP DIVING EXPERIMENT, Anxiety, 1(5), 1994, pp. 237-241
Authors:
PETIT N
DELPORTE JP
ANSSEAU M
ALBERT A
JEUSETTE F
Citation: N. Petit et al., DRUG UTILIZATION REVIEW OF ORAL FORMS OF BENZODIAZEPINES IN A BELGIAN635-BED TEACHING HOSPITAL, Pharmacy world & science, 16(4), 1994, pp. 181-186